Britta Fuenfstueck to succeed Andreas Joehle as CEO of the HARTMANN Group on January 1, 2019
- Britta Fuenfstueck to succeed Andreas Joehle as CEO of the HARTMANN Group on January 1, 2019
- She comes with several years of chief executive and healthcare industry experience
The Supervisory Board of the HARTMANN GROUP announced on October 10, 2018, the appointment of Britta Fuenfstueck as the company’s new Chief Executive Officer and Chair of HARTMANN’s Management Board. Fuenfstueck will succeed Andreas Joehle, who has been in office since 2013 and announced last year his plans to step down due to personal reasons. She will join the Management Board of HARTMANN on November 1, 2018 and will succeed Joehle as CEO on January 1, 2019.
A seasoned executive set to lead HARTMANN into the next 200 years
Britta Fuenfstueck joins HARTMANN from Clariant, a worldwide leader in specialty chemicals where she was a member of the executive committee. In this role she was responsible for the Plastics & Coatings business, as well as several corporate functions. “2018 marks 200 years since Ludwig von Hartmann founded the company in 1818. Since then, HARTMANN has grown to be a leading, global provider of medical and hygiene products,” said Fritz-Jürgen Heckmann, Chairman of the Supervisory Board of the HARTMANN GROUP. “Britta Fuenfstueck joins a distinguished line of HARTMANN leaders that have made the company what it is today. Britta will now lead us to continue our shaping of the HARTMANN of tomorrow.”
Fuenfstueck began her career in 1998 as a consultant at Boston Consulting Group. From 2000 to 2009, she held various marketing and sales positions, as well as director roles in strategy, planning and mergers & acquisitions in the healthcare division of Siemens AG in both Germany and the United States. In July 2009, at the age of 36, Fuenfstueck was given her first chief executive role when she became CEO of Siemens’ Molecular Imaging business unit in the U.S. where she led a team of over 2500 employees. Following this, in 2013 she was appointed Chief Executive Officer of the Clinical Products division at Siemens in Erlangen (Germany). There she oversaw an over 9000-person organization spread across 12 locations and served as a member of the Executive Committee at Siemens Healthcare.
An Austrian citizen, Fuenfstueck comes with a business education and studied engineering physics at Johannes-Kepler-University of Linz in Austria. There she completed her Master of Science studies with distinction in 1998.
“Joining HARTMANN is an honour for me. The growing healthcare market is in need of innovative solutions to provide better outcomes. HARTMANN is well positioned to play an even stronger role in future. I am confident that we can seize opportunities and really make a difference,” said Fuenfstueck. “People and culture are two of the most important qualities of a company and I’m looking forward to working with the HARTMANN team around the globe.”
Continuing a path towards success
During Andreas Joehle’s six-year tenure, the company experienced steady growth, reaching the two billion mark in revenue at the end of 2017. In addition, the company has continued its workforce diversification and to expand internationally with the opening of new offices in South America and Asia, as well as completing the purchase of LINDOR, the largest acquisition in the company’s history.
“We are pleased with the progress HARTMANN has made under Andreas Joehle’s leadership,” said Heckmann. “On behalf of the supervisory board and the employees of the HARTMANN GROUP, I’d like to thank him for his dedicated service and wish him and his family all the best.”
As the baton passes to Britta Fuenfstueck, Heckmann had this to add about the board’s hopes for HARTMANN’s future under her leadership. “We are very pleased that Britta will join the HARTMANN family and are confident in her ability to take HARTMANN to the next level. We offer her our full support and wish her much success as HARTMANN’s next CEO.”
Clariant welcomes Hans Bohnen as new member of the Executive Committee
Clariant, a world leader in specialty chemicals, today announced the appointment of Hans Bohnen as the newest member of its Executive Committee. Hans Bohnen has been with the company for almost 10 years and is currently Clariant’s Head of Global Business Services.
At the same time, Britta Fuenfstueck has decided to leave Clariant as of 31 October 2018 to become CEO of the Hartmann Group (see above), a leading international supplier of medical and hygiene products based in Heidenheim, Germany.
Effective 12 October 2018, Hans Bohnen will be installed as a member of Clariant’s Executive Committee. He will assume responsibility for the Business Area Plastics & Coatings, Global Business Services, Group Information Technology, Digital4Clariant, and the regions Latin America and North America.
“We are very pleased that Hans Bohnen will join the Executive Committee. With his extensive knowledge of Clariant as well as the wider chemical industry, he will be a valued contributor to the management team and will further enhance the long-term development of Clariant’s value creation capabilities for all stakeholders. We regret losing Britta Fuenfstueck and want to especially express our gratitude for her role in Clariant’s successful strategic developments over the past years. We wish her all the best in her new role”, said Hariolf Kottmann, CEO of Clariant.
Hans Bohnen is currently Head of Clariant Global Business Services, where he has built up Clariant’s internal shared service organization. Before that, he was the Senior Vice President and Head of Clariant Masterbatches. Prior to joining Clariant, he held several senior positions across Europe and North America for the SGL Group, Celanese and Hoechst AG, and worked in strategic management consultancy with Booz Allen Hamilton. Hans Bohnen studied Chemistry at the University of Duisburg-Essen, obtained a PhD in Chemistry from the University of Tübingen and holds an MBA of the Aston Business School.